MIT Sloan BioInnovations Conference Saturday, April 3, 2004
MIT Sloan School of Management
Kendall Square, Cambridge MA
If you are interested in being a sponsor of this conference this year or next year, please contact

If you are a member of the press interested in covering this conference, please contact


Lead Organizers


Mary Wheeler, PhD

MIT Sloan '04, MBA

Before Sloan Mary was a pharmaceutical management consultant. She is currently working with several start-up biotech companies and biotech VCs, is a teaching assistant for the entrepreneurship class at MIT, and is a former co-president of the Sloan BioPharma Business Club. Last summer she worked in business development for Descartes Therapeutics in Cambridge, MA. Mary holds a PhD in behavioral neuroscience from Princeton University and she graduated from Yale in 1997.


Jim Graham

MIT Sloan '04, BEP Program

Jim Graham is a second year student in the Biomedical Enterprise Program (BEP), a dual masters program sponsored by MIT-Sloan and the Harvard-MIT Division of Health Sciences and Technology (HST.) Prior to BEP, Jim worked as an investment banking analyst at Deutsche Bank Alex. Brown and as a business development manager at Extensity, Inc., an enterprise software company. He spent last summer interning in Business Planning at Biogen and will intern in the Boston office of McKinsey & Company this summer. Jim will complete BEP in December 2004.

Panel Director

Dave Berry

Harvard-MIT '05, HST Program

David Berry is a 4th yr MD/PhD candidate in Harvard Medical School and the M.I.T. Division of Health Sciences and Technology and the M.I.T. Biological Engineering Division. He was awarded a Howard Hughes Medical Institute predoctoral fellowship and was awarded a B.S. in Brain and Cognitive Science from MIT in 2000. David previously served on the M.I.T. Corporation Joint Advisory Committee as well as the M.I.T. Committee on Intellectual Property. He is currently chair of the M.I.T. Academics, Research, and Careers committee through the Graduate Student Council. He was previously a finalist in the MIT $50K Entrepreneurship Competition in 2001.

Panel Director

Shamit Mehta

MIT Sloan '04, MBA

Prior to coming to Sloan, Shamit spent 4 years with the Boston Consulting Group in New York, most recently as a senior consultant. While at BCG, he worked on several projects in the pharmaceutical industry.

During the past year, Shamit interned with Pfizer's Global Market Analytics group focusing on an anti-migraine product, and with Oxford Bioscience to analyze biotech stock returns. After graduation, he will be returning to BCG's New York office.

Shamit holds a BS in Economics with a focus on Accounting and Finance from the Wharton School of the University of Pennsylvania.

Special Events Coordinator

Jeb Keiper MS

MIT Sloan '04, MBA

Jeb Keiper is currently completing his MBA at the MIT Sloan School of Management while taking classes in Pharmacology at Harvard Medical School. Jeb actively consults for a number of biotech and life science companies, and is a former Co-President of the Sloan BioPharma Business Club.

Jeb spent the Summer of 2004 in Business Development with TransForm Pharmaceuticals. Prior to Sloan, Jeb worked for McKinsey & Company in their Pharmaceuticals and Medical Products Practice both as an analyst and manager, where he led a number of client teams on projects in R&D Product/Portfolio Strategy, Business Development, and Corporate Valuation. Jeb received his Masters and Bachelors degrees in Chemical Engineering from MIT.

Digital Communications Director

Anita Khosla

MIT Sloan '05, MBA

Prior to beginning her MBA at Sloan, Anita spent six years in technology consulting. Her clients include a major pharmaceutical company for which she helped build a knowledge management solution to provide post-FDA approval and commercialization support of products. In addition to working for a large consulting company, Anita has worked for an internet consulting startup, and most recently, was self-employed as an independent consultant for a non-profit client. Anita received her BS in Information Systems/Finance from New York University's Stern School of Business in 1997.

Marketing and Publicity Director

Issi Rozen

MIT Sloan '05, MBA

Issi Rozen is a professor at Berklee College of Music, the founder and president of New Step Music and the guitarist and leader of the critically acclaimed jazz group, the Issi Rozen Quartet. He produced and released three critically acclaimed CDs, Red Sea, Homeland Blues and Dark Beauty. Issi was also responsible for national marketing and promotion of the releases, including radio and print promotion, publicity and e-marketing. His recording, Homeland Blues, was picked as one of the top 20 jazz CDs in 2000. Additionally, he received the "Best Jazz Performer" award from Boston Magazine. Issi Rozen is currently an MBA candidate at the MIT Sloan School of Management and has a strong interest in the biotech industry.

Logistics Director

John Fesko

MIT Sloan '05, MBA

Before attending Sloan, John worked for the biotech startups InVivoScribe Technologies and TransloGen Diagnostics. As manager of business development and operations, he helped build InVivoScribe into the world leader in molecular diagnostic products for blood born cancers. John holds a BS in Biochemistry and Economics from the University of Notre Dame.

Print Communications Director

Vipin Gupta

MIT Sloan '05, MBA

Vipin is a first year MBA and a PhD student in the department of Chemical Engineering at MIT. Prior to Sloan, Vipin worked in the Bioinformatics and Functional Genomics group at MIT for three years where he collaborated with IBM to develop tools for genomic sequence analysis.

During the spring of 2003, Vipin worked with Agamatrix, a medical devices startup in Cambridge, and conducted a value-proposition analysis for identifying a new market for their core technology. As a technical consultant with General Mills in the summer of 2001, a cereals manufacturing company, Vipin led a team of graduate students to troubleshoot manufacturing operations in their Buffalo division. Vipin holds a BS in Chemical Engineering from the Indian Institute of Technology.

with the MIT Sloan BioPharma Business Club

Panel Leads

Matt Vokoun

MIT Sloan MBA & MS Chemical Engineering '05

Matt Vokoun is currently a first-year graduate student in the MIT Leaders for Manufacturing (LFM) program, pursuing his MBA and MS Chemical Engineering. He received his BS Chemical Engineering from the University of Wisconsin in 1998. Matt's work experience over the last five years has focused on high-tech manufacturing and supply chain management. He spent 2 years in supply chain software consulting at i2 Technologies, 1 year in operations management at an internet start-up, and 2 years in optical film and electronic display manufacturing at 3M. Matt is currently an LFM intern at the MIT Broad Genome Center.

Richard J. Resnick

MIT Sloan Management of Technology '04

Richard is a ten year entrepreneur in the life sciences. He founded and successfully sold off Mosaic Bioinformatics to NetGenics, Inc. in May, 2000, and has consulted to various seed and early stage companies such as Gene-IT, Blackstone Computing, GeneGo, and Phylos. He took a year off to earn a mid-career M.B.A. fr NetGenics, Inc. in May, 2000, and has consulted to various seed and early stage companies such as Gene-IT, Blackstone Computing, GeneGo, and Phylos. He took a year off to earn a mid-career M.B.A. from MIT's Sloan School of Management, which he completes in May, 2004. Richard has recently founded Biological Energy Corporation, developing biological approaches to the production of hydrogen.

Nimish Parikh

MIT Sloan MBA '05

Prior to joining Sloan's MBA program, Nimish Parikh's career spanned diverse sectors of the healthcare industry, including healthcare IT, medical devices, and biopharmaceuticals. After graduating from Brown University in 1996, he worked for a healthcare venture capital firm, and later founded and sold a start-up healthcare software business. His interest in neuroimaging comes from his most recent role as part of the business development team at Sention Pharmaceuticals, a CNS drug discovery company.

Dr. Jeffrey B. Moore

MIT Sloan Fellow '04

Dr. Moore is currently studying towards his MBA in the Sloan Fellows executive program at MIT. Previously, he worked at Millennium Pharmaceuticals and Scriptgen (now Anadys), with various roles in business development, bioinformatics and competitive intelligence. He received his PhD in poxvirus biology from the University of Oxford, and was a research fellow at Harvard Medical School. He also recently completed an internship at MPM Capital in Boston.

Fabio A. Thiers, MD

Harvard-MIT (HST) PhD '05

Dr. Fabio Thiers is a Ph.D. candidate ('05) of the Harvard-MIT Division of Health Sciences and Technology (HST). Before joining this program, he spent three years as a postdoctoral fellow at the Harvard Medical School/Massachusetts Eye & Ear Infirmary. Dr. Thiers obtained his M.D. from the Brazilian Federal University of Pernambuco in 1998, and has completed the requirements for medical certification in the United States. Dr. Thiers' research work is focused on hearing disorders. He also has a particular interest in the management of clinical trials of new drugs and devices for FDA appraisal.

Erik Yazdani

MIT Sloan MBA '05

Prior to pursuing his MBA at MIT Sloan, Erik worked for three enterprise software startups. As a Business Analyst with Edusoft, a provider of K-12 educational assessment software, he led product marketing and human resources initiatives. Prior to Edusoft, Erik worked as a Product and Program Manager for two early stage software companies, Talaris Corporation and, a subsidiary of MicroStrategy, Inc. In 2002, Erik helped co-found the Social Entrepreneurship Initiative, an organization supporting social entrepreneurs using technology to address social needs.

Erik received his BS in Mechanical Engineering with honors from Cornell University.


Ken Morse

Director, MIT Entrepreneurship Center

Janice Bourque

CEO, Massachusetts Biotech Council

Fiona Murray

Professor, MIT Sloan

Jason Rubin

President, The Redstone Group LLC

Ernst Berndt

Professor, MIT Sloan and NBER

Mary Schaefer

Director, MIT Sloan Corporate Relations


Find out about the MIT Sloan VCPE Symposium

Find out about the Kellogg Biotech Conference